129.06 USD
↗ 0.00 (0.00%)AT CLOSE (11:59 AM EDT)
Inhibrx Biosciences, Inc. Common Stock
INBXNASDAQ • USD
126.06
↘ 3.00 (2.32%)
POST MARKET (AS OF 07:47 PM EDT)
Post Market
AS OF 07:47 PM EDT
126.06
↘ 3.00 (2.32%)
Market: CLOSED
Open?$121.19
High?$129.60
Low?$116.60
Prev. Close?$129.06
Volume?617.2K
Avg. Volume?380.7K
VWAP?$124.60
Rel. Volume?1.62x
Bid / Ask
Bid?$121.12 × 200
Ask?$131.00 × 100
Spread?$9.88
Midpoint?$126.06
Valuation & Ratios
Market Cap?1.9B
Shares Out?14.6M
Float?7.7M
Float %?53.0%
P/E Ratio?N/A
P/B Ratio?235.86
EPS?-$9.59
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?3.93Strong
Quick Ratio?3.93Strong
Cash Ratio?3.68Strong
Debt/Equity?12.58High
ValuationRICHLY VALUED
Score50/100
P/E?N/A▾
P/B?235.86HIGH▾
P/S?1,450.17HIGH▾
P/FCF?N/A▾
EV/EBITDA?-14.1CHEAP▾
EV/Sales?1,431.97HIGH▾
Returns & Efficiency
ROE?-1,752.2%WEAK▾
ROA?-95.6%WEAK▾
Cash Flow & Enterprise
FCF?$-129825000
Enterprise Value?$1.9B
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Employees
110
Market Cap
1.9B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2024-05-28
Address
11025 N. TORREY PINES ROAD, SUITE 140
LA JOLLA, CA 92037
Phone: (858) 795-4220
LA JOLLA, CA 92037
Phone: (858) 795-4220